This report provides an in-depth analysis of the North America Urology Devices Market, examining key drivers, industry trends, market opportunities, and recent developments from 2020 to 2035. It offers valuable insights into revenue trends and regional market share, supported by the latest data and industry developments.
The economic impact of tariffs on "North America Urology Devices Market".
Market Growth Drivers
The increasing prevalence of urological disorders, such as benign prostatic hyperplasia (BPH), urinary incontinence, and kidney stones, is a significant growth driver for the North America Urology Devices Market. According to Boston Scientific, there is a notable rise in the demand for minimally invasive procedures due to an aging population and improved awareness. Hospitals and specialty clinics across North America are investing in advanced urology equipment to enhance patient care and outcomes, which is expected to contribute substantially to market growth in the coming years.
Technological advancements in urology devices, including the integration of robotics, artificial intelligence, and 3D imaging, are propelling market expansion. Medtronic has recently expanded its suite of urology products, focusing on greater accuracy and safety for procedures like lithotripsy and endoscopy. These innovations not only improve clinical outcomes but also decrease hospital stays, further boosting product adoption across the region.
Market Trends
A key trend shaping the North America Urology Devices Market is the rapid shift towards outpatient and ambulatory care for urological procedures. Companies like Olympus Corporation are developing compact, portable endoscopic devices that support less invasive, same-day interventions, driving adoption across ambulatory surgical centers and outpatient clinics. This trend significantly reduces costs for healthcare providers and improves patient turnaround.
Another emerging trend is the rise of telemedicine and remote monitoring solutions for urological care. BD (Becton, Dickinson and Company) has launched digital platforms and smart catheters that enable real-time monitoring and patient data analytics, facilitating early intervention and personalized treatment plans. This digital transformation helps providers deliver more efficient care, especially for chronic urological diseases, and is expected to shape future product development.
Market Opportunities
Expansion of urology device manufacturers into untapped rural and remote healthcare settings presents a significant market opportunity. Companies like Coloplast are collaborating with regional healthcare providers to improve device accessibility and training, which can meet the high unmet needs for urological care in less urbanized areas.
The increasing adoption of single-use and disposable urology devices to reduce hospital-acquired infections is another lucrative opportunity. The ongoing focus on infection control post-pandemic, as highlighted by Teleflex Medical, suggests growing demand for single-use catheters and cystoscopes across North American healthcare settings.
North America Urology Devices Market Revenue (USD Million), 2020-2035
The chart below illustrates the consistent revenue growth of the North America Urology Devices Market from 2020 through 2035. Beginning at USD 6800 Million in 2020, the market experiences steady expansion, propelled by rising demand for minimally invasive urological treatments, technological innovations, and increased healthcare spending. An observable surge occurs post-2025, likely attributable to the wider adoption of digital health solutions and next-generation devices. By 2035, the market is projected to reach approximately USD 15,800 Million, reflecting a compound annual growth rate (CAGR) of 7.8%. This upward trajectory underscores strong market fundamentals and signals significant investment opportunities for stakeholders.
North America Urology Devices Market Share by Region, 2025
The 2025 regional market share breakdown visually demonstrates the dominance of the United States, holding 78% of the North America Urology Devices Market value. Canada follows with a 16% share, driven by growing investment in healthcare infrastructure and the expansion of specialized urology centers. Mexico captures 4%, reflecting increasing healthcare access and gradual adoption of advanced urology devices. The remaining 2% is shared among Other North American countries and the Caribbean. This distribution reflects robust market demand in the US, with emerging growth potential in adjacent regions.
Recent Market Developments
In April 2024, Boston Scientific announced the launch of a new radiofrequency ablation system for the management of benign prostatic hyperplasia (BPH). This next-generation system utilizes AI-guided imaging to improve precision and patient safety, and has garnered interest from large urology centers across the US following its FDA clearance. The move strengthens Boston Scientific’s position as a leader in minimally invasive urology treatments.
In March 2024, Medtronic completed the acquisition of a Canadian urology device start-up specializing in smart, single-use cystoscopes. This acquisition expands Medtronic's digital health portfolio and leverages cutting-edge imaging technologies, allowing the company to provide enhanced diagnostic and therapeutic solutions for hospital networks and ambulatory surgical centers throughout North America.
BD (Becton, Dickinson and Company) rolled out a new remote patient monitoring platform in May 2024, integrating wearable sensor technology with its portfolio of urology catheters. The platform enables continuous monitoring of urinary function, facilitates early intervention for complications, and aligns with growing telehealth adoption. Healthcare providers using the system report improved patient adherence and satisfaction, indicating a positive market reception.
Press Releases